Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.03880864 |
2 | negative regulation of interleukin-12 production (GO:0032695) | 4.79263928 |
3 | daunorubicin metabolic process (GO:0044597) | 4.71057980 |
4 | polyketide metabolic process (GO:0030638) | 4.71057980 |
5 | doxorubicin metabolic process (GO:0044598) | 4.71057980 |
6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.58223080 |
7 | detection of molecule of bacterial origin (GO:0032490) | 4.33581865 |
8 | positive regulation of type 2 immune response (GO:0002830) | 4.27863360 |
9 | proline transport (GO:0015824) | 4.12347333 |
10 | response to peptidoglycan (GO:0032494) | 4.11617919 |
11 | phagosome maturation (GO:0090382) | 3.90581719 |
12 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.78971052 |
13 | positive regulation by symbiont of host defense response (GO:0052509) | 3.75385040 |
14 | modulation by symbiont of host defense response (GO:0052031) | 3.75385040 |
15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.75385040 |
16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.75385040 |
17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.75385040 |
18 | modulation by symbiont of host immune response (GO:0052553) | 3.75385040 |
19 | synaptic vesicle exocytosis (GO:0016079) | 3.72763011 |
20 | detection of other organism (GO:0098543) | 3.72071282 |
21 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.70258877 |
22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.69893924 |
23 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.69276310 |
24 | detection of external biotic stimulus (GO:0098581) | 3.54966071 |
25 | neutrophil activation involved in immune response (GO:0002283) | 3.54736046 |
26 | regulation of gamma-delta T cell activation (GO:0046643) | 3.48821342 |
27 | T-helper 1 type immune response (GO:0042088) | 3.48593597 |
28 | cellular extravasation (GO:0045123) | 3.47698204 |
29 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.43321353 |
30 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.42563257 |
31 | reactive oxygen species biosynthetic process (GO:1903409) | 3.41763020 |
32 | regulation of T cell tolerance induction (GO:0002664) | 3.37132479 |
33 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.37112698 |
34 | synaptic vesicle maturation (GO:0016188) | 3.35479094 |
35 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.34893253 |
36 | regulation of type 2 immune response (GO:0002828) | 3.31563403 |
37 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.29378153 |
38 | detection of bacterium (GO:0016045) | 3.27047487 |
39 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.26599864 |
40 | superoxide anion generation (GO:0042554) | 3.26521463 |
41 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.26478352 |
42 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.20365515 |
43 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.20337874 |
44 | transferrin transport (GO:0033572) | 3.20000883 |
45 | regulation of interleukin-12 production (GO:0032655) | 3.18920012 |
46 | positive regulation of mast cell activation (GO:0033005) | 3.17711130 |
47 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.17271989 |
48 | regulation of tolerance induction (GO:0002643) | 3.15825336 |
49 | positive regulation of interferon-alpha production (GO:0032727) | 3.15495434 |
50 | detection of biotic stimulus (GO:0009595) | 3.15372608 |
51 | macrophage activation involved in immune response (GO:0002281) | 3.15178822 |
52 | protein localization to synapse (GO:0035418) | 3.14999666 |
53 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.14301657 |
54 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.14277194 |
55 | glutamate secretion (GO:0014047) | 3.12329748 |
56 | respiratory burst (GO:0045730) | 3.12056710 |
57 | neutrophil mediated immunity (GO:0002446) | 3.11750268 |
58 | negative regulation of amino acid transport (GO:0051956) | 3.11247159 |
59 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.10726573 |
60 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.09309670 |
61 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.08624896 |
62 | response to host immune response (GO:0052572) | 3.08624896 |
63 | immunoglobulin mediated immune response (GO:0016064) | 3.08500013 |
64 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.05654027 |
65 | positive regulation of antigen processing and presentation (GO:0002579) | 3.05454009 |
66 | positive regulation of heat generation (GO:0031652) | 3.05437699 |
67 | negative regulation of T cell mediated immunity (GO:0002710) | 3.04834796 |
68 | B cell mediated immunity (GO:0019724) | 3.01247219 |
69 | mitochondrion distribution (GO:0048311) | 3.01188077 |
70 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.00843079 |
71 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.00529455 |
72 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.99378082 |
73 | microglial cell activation (GO:0001774) | 2.99160504 |
74 | regulation of mast cell degranulation (GO:0043304) | 2.96796649 |
75 | T cell migration (GO:0072678) | 2.96706520 |
76 | positive regulation of interleukin-12 production (GO:0032735) | 2.96363248 |
77 | negative regulation of interleukin-17 production (GO:0032700) | 2.96303981 |
78 | regulation of interferon-alpha production (GO:0032647) | 2.95407256 |
79 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.95077422 |
80 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.94541145 |
81 | trivalent inorganic cation transport (GO:0072512) | 2.93652108 |
82 | ferric iron transport (GO:0015682) | 2.93652108 |
83 | lymphocyte chemotaxis (GO:0048247) | 2.93376851 |
84 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.93100266 |
85 | response to protozoan (GO:0001562) | 2.92314590 |
86 | regulation of antigen processing and presentation (GO:0002577) | 2.92137711 |
87 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.91743252 |
88 | regulation of T-helper cell differentiation (GO:0045622) | 2.91365940 |
89 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.90490760 |
90 | positive regulation of interleukin-10 production (GO:0032733) | 2.89804379 |
91 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.89664896 |
92 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.89575586 |
93 | germinal center formation (GO:0002467) | 2.87218567 |
94 | neuron cell-cell adhesion (GO:0007158) | 2.86909929 |
95 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.86852076 |
96 | regulation of fever generation (GO:0031620) | 2.86728699 |
97 | regulation of interleukin-17 production (GO:0032660) | 2.86003557 |
98 | regulation of synaptic vesicle transport (GO:1902803) | 2.84886554 |
99 | myeloid leukocyte mediated immunity (GO:0002444) | 2.82858650 |
100 | vocalization behavior (GO:0071625) | 2.80249589 |
101 | response to histamine (GO:0034776) | 2.79862325 |
102 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.78486058 |
103 | regulation of mast cell activation (GO:0033003) | 2.78347963 |
104 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.78143067 |
105 | cellular response to interferon-gamma (GO:0071346) | 2.77858168 |
106 | positive regulation of tolerance induction (GO:0002645) | 2.75764908 |
107 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.75241554 |
108 | myeloid dendritic cell differentiation (GO:0043011) | 2.74652128 |
109 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.73244091 |
110 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.71962712 |
111 | granulocyte activation (GO:0036230) | 2.71755921 |
112 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.70632110 |
113 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.70561196 |
114 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.70561196 |
115 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.70474702 |
116 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.69208343 |
117 | response to interferon-gamma (GO:0034341) | 2.67375531 |
118 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.66645403 |
119 | regulation of chemokine biosynthetic process (GO:0045073) | 2.66397610 |
120 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.66105325 |
121 | neutrophil activation (GO:0042119) | 2.65409557 |
122 | type I interferon signaling pathway (GO:0060337) | 2.64250026 |
123 | cellular response to type I interferon (GO:0071357) | 2.64250026 |
124 | regulation of glutamate secretion (GO:0014048) | 2.64130318 |
125 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.62816379 |
126 | myeloid cell activation involved in immune response (GO:0002275) | 2.62298117 |
127 | glutamate receptor signaling pathway (GO:0007215) | 2.61422155 |
128 | neurotransmitter secretion (GO:0007269) | 2.60257685 |
129 | neuron-neuron synaptic transmission (GO:0007270) | 2.59462403 |
130 | synaptic vesicle endocytosis (GO:0048488) | 2.58575286 |
131 | intracellular pH reduction (GO:0051452) | 2.57688526 |
132 | response to type I interferon (GO:0034340) | 2.56200638 |
133 | response to host (GO:0075136) | 2.55981534 |
134 | response to host defenses (GO:0052200) | 2.55981534 |
135 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.55981534 |
136 | defense response to protozoan (GO:0042832) | 2.55590867 |
137 | synaptic transmission, glutamatergic (GO:0035249) | 2.54850046 |
138 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.54563411 |
139 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.54135982 |
140 | positive regulation of mast cell degranulation (GO:0043306) | 2.54135982 |
141 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.52739191 |
142 | negative regulation of viral genome replication (GO:0045071) | 2.51821666 |
143 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.51537814 |
144 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.51388955 |
145 | response to muramyl dipeptide (GO:0032495) | 2.48134792 |
146 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.46306250 |
147 | natural killer cell mediated immunity (GO:0002228) | 2.46306250 |
148 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.43624225 |
149 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.41395531 |
150 | serotonin receptor signaling pathway (GO:0007210) | 2.38057113 |
151 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.37917252 |
152 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.37443917 |
153 | macrophage activation (GO:0042116) | 2.37376917 |
154 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.36751445 |
155 | neuronal action potential propagation (GO:0019227) | 2.36742949 |
156 | response to interferon-alpha (GO:0035455) | 2.34516765 |
157 | leukocyte mediated cytotoxicity (GO:0001909) | 2.33234091 |
158 | negative regulation of cell killing (GO:0031342) | 2.32358885 |
159 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.32358885 |
160 | eosinophil chemotaxis (GO:0048245) | 2.31865849 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.93785419 |
2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.47460938 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.96567420 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.87819030 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.58445845 |
6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.97801936 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.85884729 |
8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.82706686 |
9 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.79780428 |
10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.77808091 |
11 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.70724979 |
12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.59865357 |
13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.51927646 |
14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.51927296 |
15 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.50478632 |
16 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.43800314 |
17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.41988811 |
18 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.38077448 |
19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.31719662 |
20 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.31542178 |
21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.24881366 |
22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.24513855 |
23 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.16241989 |
24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12933987 |
25 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.11146872 |
26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.08861579 |
27 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.07981201 |
28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.97899081 |
29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86951237 |
30 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.81720514 |
31 | P300_19829295_ChIP-Seq_ESCs_Human | 1.80728290 |
32 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.80481751 |
33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79003194 |
34 | * MYB_26560356_Chip-Seq_TH2_Human | 1.77436386 |
35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.74126177 |
36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.73655458 |
37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.73406913 |
38 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.72151969 |
39 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 1.71545847 |
40 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.69377411 |
41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.65777993 |
42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.64729548 |
43 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.61625484 |
44 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60285428 |
45 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.57561404 |
46 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.54404600 |
47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51846165 |
48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49244036 |
49 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.48910231 |
50 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.46111447 |
51 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44517046 |
52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.42252498 |
53 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40408200 |
54 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.40220726 |
55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39597103 |
56 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.39327578 |
57 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38721668 |
58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.38602375 |
59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38370796 |
60 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.38061012 |
61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36756793 |
62 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.34705003 |
63 | FUS_26573619_Chip-Seq_HEK293_Human | 1.34479633 |
64 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.33518788 |
65 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.33445006 |
66 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.33415674 |
67 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.31164826 |
68 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.30637441 |
69 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.29610155 |
70 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.28012558 |
71 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.27389603 |
72 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.26181551 |
73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24370556 |
74 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.24091334 |
75 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.23553823 |
76 | MYB_26560356_Chip-Seq_TH1_Human | 1.23326625 |
77 | * MAF_26560356_Chip-Seq_TH1_Human | 1.23276890 |
78 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22943898 |
79 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.22015547 |
80 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.21081228 |
81 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21040088 |
82 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20945568 |
83 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.19252131 |
84 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.17910469 |
85 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16964109 |
86 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16702732 |
87 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.16595617 |
88 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16431212 |
89 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.16412250 |
90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15961523 |
91 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.15743306 |
92 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.14992216 |
93 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14707007 |
94 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14123471 |
95 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13872957 |
96 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.13421220 |
97 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.13000280 |
98 | JUN_21703547_ChIP-Seq_K562_Human | 1.12032719 |
99 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.11326516 |
100 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.10337927 |
101 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.09882890 |
102 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.09731077 |
103 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.09731077 |
104 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09214058 |
105 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.08863010 |
106 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08691549 |
107 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.08039322 |
108 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.07547791 |
109 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07424519 |
110 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.07094265 |
111 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06528064 |
112 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.05922184 |
113 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05258863 |
114 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.04633229 |
115 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04045155 |
116 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03812020 |
117 | VDR_22108803_ChIP-Seq_LS180_Human | 1.02849538 |
118 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.02835404 |
119 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.01470259 |
120 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.01238646 |
121 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.01238646 |
122 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.01101278 |
123 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.01090318 |
124 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.00814437 |
125 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00614897 |
126 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00443780 |
127 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99627277 |
128 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99604370 |
129 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.99541146 |
130 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99207588 |
131 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.98795396 |
132 | TCF4_23295773_ChIP-Seq_U87_Human | 0.98252003 |
133 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97974673 |
134 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97662479 |
135 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97477541 |
136 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97477541 |
137 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96649175 |
138 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.95144459 |
139 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.94789265 |
140 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94598902 |
141 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.92881217 |
142 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.92798025 |
143 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.92446009 |
144 | UTX_26944678_Chip-Seq_JUKART_Human | 0.91167855 |
145 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90827733 |
146 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.90691545 |
147 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.88526800 |
148 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86610403 |
149 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.83503684 |
150 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.83009211 |
151 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79855429 |
152 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.77975376 |
153 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.77063795 |
154 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.77045107 |
155 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74877446 |
156 | MAF_26560356_Chip-Seq_TH2_Human | 0.73572558 |
157 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.71024519 |
158 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.70346520 |
159 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.70097567 |
160 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.69573953 |
161 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.66986541 |
162 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65981438 |
163 | GATA1_19941826_ChIP-Seq_K562_Human | 0.65762958 |
164 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.64912072 |
165 | GATA2_19941826_ChIP-Seq_K562_Human | 0.63267704 |
166 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.63016456 |
167 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.62701474 |
168 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.59544344 |
169 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.59260879 |
170 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.57286804 |
171 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.55762287 |
172 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.55739773 |
173 | GATA3_26560356_Chip-Seq_TH1_Human | 0.54012785 |
174 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.53717443 |
175 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.52385847 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 3.69991260 |
2 | MP0003880_abnormal_central_pattern | 3.55303836 |
3 | MP0001835_abnormal_antigen_presentation | 3.12490131 |
4 | MP0001968_abnormal_touch/_nociception | 2.77011645 |
5 | MP0009046_muscle_twitch | 2.67049895 |
6 | MP0002735_abnormal_chemical_nociception | 2.60061273 |
7 | MP0001501_abnormal_sleep_pattern | 2.58715157 |
8 | MP0009785_altered_susceptibility_to | 2.53552279 |
9 | MP0004858_abnormal_nervous_system | 2.50606270 |
10 | MP0003635_abnormal_synaptic_transmissio | 2.49004903 |
11 | MP0009745_abnormal_behavioral_response | 2.44608026 |
12 | MP0002736_abnormal_nociception_after | 2.37968435 |
13 | MP0002148_abnormal_hypersensitivity_rea | 2.35747482 |
14 | MP0002064_seizures | 2.33886923 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.31031563 |
16 | MP0002063_abnormal_learning/memory/cond | 2.18943615 |
17 | MP0002876_abnormal_thyroid_physiology | 2.14244061 |
18 | MP0003690_abnormal_glial_cell | 2.11508789 |
19 | MP0000569_abnormal_digit_pigmentation | 2.11442405 |
20 | MP0005058_abnormal_lysosome_morphology | 2.07807612 |
21 | MP0006082_CNS_inflammation | 2.06460539 |
22 | MP0002572_abnormal_emotion/affect_behav | 2.04153124 |
23 | MP0003183_abnormal_peptide_metabolism | 2.03808280 |
24 | MP0004270_analgesia | 2.00312387 |
25 | MP0004510_myositis | 1.98311661 |
26 | MP0002734_abnormal_mechanical_nocicepti | 1.98149383 |
27 | MP0002733_abnormal_thermal_nociception | 1.96894935 |
28 | MP0003300_gastrointestinal_ulcer | 1.91147665 |
29 | MP0002419_abnormal_innate_immunity | 1.87163409 |
30 | MP0003436_decreased_susceptibility_to | 1.85398062 |
31 | MP0002822_catalepsy | 1.83977875 |
32 | MP0005671_abnormal_response_to | 1.81774464 |
33 | MP0005025_abnormal_response_to | 1.79312246 |
34 | MP0005000_abnormal_immune_tolerance | 1.78439838 |
35 | MP0006276_abnormal_autonomic_nervous | 1.78176527 |
36 | MP0006292_abnormal_olfactory_placode | 1.75336378 |
37 | MP0001970_abnormal_pain_threshold | 1.75151805 |
38 | MP0003195_calcinosis | 1.71402261 |
39 | MP0001440_abnormal_grooming_behavior | 1.69370312 |
40 | MP0002139_abnormal_hepatobiliary_system | 1.64937054 |
41 | MP0003172_abnormal_lysosome_physiology | 1.64229916 |
42 | MP0003724_increased_susceptibility_to | 1.63477671 |
43 | MP0002254_reproductive_system_inflammat | 1.62035521 |
44 | MP0002272_abnormal_nervous_system | 1.61015516 |
45 | MP0010386_abnormal_urinary_bladder | 1.60510308 |
46 | MP0002277_abnormal_respiratory_mucosa | 1.59633903 |
47 | MP0005387_immune_system_phenotype | 1.58668934 |
48 | MP0001790_abnormal_immune_system | 1.58668934 |
49 | MP0002405_respiratory_system_inflammati | 1.56139514 |
50 | MP0001188_hyperpigmentation | 1.53557454 |
51 | MP0005423_abnormal_somatic_nervous | 1.47046305 |
52 | MP0003787_abnormal_imprinting | 1.46504600 |
53 | MP0002332_abnormal_exercise_endurance | 1.45787002 |
54 | MP0004947_skin_inflammation | 1.42900792 |
55 | MP0002723_abnormal_immune_serum | 1.42859612 |
56 | MP0001486_abnormal_startle_reflex | 1.40664985 |
57 | MP0002067_abnormal_sensory_capabilities | 1.40573605 |
58 | MP0002452_abnormal_antigen_presenting | 1.40145500 |
59 | MP0010155_abnormal_intestine_physiology | 1.35947917 |
60 | MP0009278_abnormal_bone_marrow | 1.34941852 |
61 | MP0005451_abnormal_body_composition | 1.34250951 |
62 | MP0005310_abnormal_salivary_gland | 1.33736646 |
63 | MP0003075_altered_response_to | 1.33656256 |
64 | MP0001800_abnormal_humoral_immune | 1.31063859 |
65 | MP0009333_abnormal_splenocyte_physiolog | 1.30330090 |
66 | MP0003011_delayed_dark_adaptation | 1.28237610 |
67 | MP0002398_abnormal_bone_marrow | 1.27470766 |
68 | MP0005166_decreased_susceptibility_to | 1.27135556 |
69 | MP0001819_abnormal_immune_cell | 1.27008122 |
70 | MP0009840_abnormal_foam_cell | 1.26407195 |
71 | MP0005464_abnormal_platelet_physiology | 1.26165971 |
72 | MP0001545_abnormal_hematopoietic_system | 1.25996926 |
73 | MP0005397_hematopoietic_system_phenotyp | 1.25996926 |
74 | MP0004924_abnormal_behavior | 1.25221250 |
75 | MP0005386_behavior/neurological_phenoty | 1.25221250 |
76 | MP0005646_abnormal_pituitary_gland | 1.24980311 |
77 | MP0009764_decreased_sensitivity_to | 1.24792252 |
78 | MP0000920_abnormal_myelination | 1.24443756 |
79 | MP0001986_abnormal_taste_sensitivity | 1.24274115 |
80 | MP0002420_abnormal_adaptive_immunity | 1.22844957 |
81 | MP0005535_abnormal_body_temperature | 1.21853827 |
82 | MP0002998_abnormal_bone_remodeling | 1.19752717 |
83 | MP0003329_amyloid_beta_deposits | 1.17244476 |
84 | MP0005174_abnormal_tail_pigmentation | 1.16980783 |
85 | MP0005075_abnormal_melanosome_morpholog | 1.15623840 |
86 | MP0004142_abnormal_muscle_tone | 1.14293180 |
87 | MP0001905_abnormal_dopamine_level | 1.13437324 |
88 | MP0003303_peritoneal_inflammation | 1.12373105 |
89 | MP0001984_abnormal_olfaction | 1.11943574 |
90 | MP0000015_abnormal_ear_pigmentation | 1.11075935 |
91 | MP0004883_abnormal_blood_vessel | 1.10643915 |
92 | MP0003806_abnormal_nucleotide_metabolis | 1.08410924 |
93 | MP0000689_abnormal_spleen_morphology | 1.07932821 |
94 | MP0000685_abnormal_immune_system | 1.07103971 |
95 | MP0003656_abnormal_erythrocyte_physiolo | 1.06655635 |
96 | MP0005645_abnormal_hypothalamus_physiol | 1.05634557 |
97 | MP0003879_abnormal_hair_cell | 1.04841232 |
98 | MP0002429_abnormal_blood_cell | 1.04639537 |
99 | MP0005164_abnormal_response_to | 1.04497334 |
100 | MP0002638_abnormal_pupillary_reflex | 1.03003329 |
101 | MP0004811_abnormal_neuron_physiology | 1.01328761 |
102 | MP0003633_abnormal_nervous_system | 1.01195408 |
103 | MP0000858_altered_metastatic_potential | 1.00788104 |
104 | MP0002090_abnormal_vision | 0.99110168 |
105 | MP0008874_decreased_physiological_sensi | 0.98679212 |
106 | MP0002184_abnormal_innervation | 0.98430135 |
107 | MP0008004_abnormal_stomach_pH | 0.97438191 |
108 | MP0002722_abnormal_immune_system | 0.97411095 |
109 | MP0009763_increased_sensitivity_to | 0.96875151 |
110 | MP0001845_abnormal_inflammatory_respons | 0.93840882 |
111 | MP0003866_abnormal_defecation | 0.93354010 |
112 | MP0006035_abnormal_mitochondrial_morpho | 0.92560052 |
113 | MP0003828_pulmonary_edema | 0.92365039 |
114 | MP0003122_maternal_imprinting | 0.92126957 |
115 | MP0000465_gastrointestinal_hemorrhage | 0.91575366 |
116 | MP0001853_heart_inflammation | 0.89285495 |
117 | MP0008872_abnormal_physiological_respon | 0.88777300 |
118 | MP0005167_abnormal_blood-brain_barrier | 0.88250115 |
119 | MP0002557_abnormal_social/conspecific_i | 0.88090744 |
120 | MP0008260_abnormal_autophagy | 0.85062755 |
121 | MP0009765_abnormal_xenobiotic_induced | 0.84331516 |
122 | MP0002132_abnormal_respiratory_system | 0.83526512 |
123 | MP0000372_irregular_coat_pigmentation | 0.83224140 |
124 | MP0008469_abnormal_protein_level | 0.82979014 |
125 | MP0000343_altered_response_to | 0.81598834 |
126 | MP0000604_amyloidosis | 0.80944507 |
127 | MP0002138_abnormal_hepatobiliary_system | 0.80315912 |
128 | MP0002006_tumorigenesis | 0.80197323 |
129 | MP0000716_abnormal_immune_system | 0.80056052 |
130 | MP0001529_abnormal_vocalization | 0.80028159 |
131 | MP0004782_abnormal_surfactant_physiolog | 0.79753459 |
132 | MP0003763_abnormal_thymus_physiology | 0.79185066 |
133 | MP0001851_eye_inflammation | 0.78374809 |
134 | MP0002909_abnormal_adrenal_gland | 0.77460631 |
135 | MP0003448_altered_tumor_morphology | 0.77138381 |
136 | MP0001533_abnormal_skeleton_physiology | 0.73551145 |
137 | MP0003631_nervous_system_phenotype | 0.73334952 |
138 | MP0008569_lethality_at_weaning | 0.73327946 |
139 | MP0002166_altered_tumor_susceptibility | 0.66715515 |
140 | MP0000371_diluted_coat_color | 0.66347454 |
141 | MP0002693_abnormal_pancreas_physiology | 0.65017341 |
142 | MP0004381_abnormal_hair_follicle | 0.56061032 |
143 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.55925419 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 5.52125382 |
2 | Febrile seizures (HP:0002373) | 4.90160546 |
3 | Recurrent abscess formation (HP:0002722) | 4.83116488 |
4 | Recurrent bacterial skin infections (HP:0005406) | 4.54215689 |
5 | Eczematoid dermatitis (HP:0000976) | 4.12814847 |
6 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.98897020 |
7 | Epileptic encephalopathy (HP:0200134) | 3.90834875 |
8 | Hypothermia (HP:0002045) | 3.72045143 |
9 | Increased IgM level (HP:0003496) | 3.69790140 |
10 | Atonic seizures (HP:0010819) | 3.69530004 |
11 | Hyperventilation (HP:0002883) | 3.63127475 |
12 | Focal seizures (HP:0007359) | 3.58245927 |
13 | Keratoconjunctivitis sicca (HP:0001097) | 3.49735105 |
14 | Mediastinal lymphadenopathy (HP:0100721) | 3.47898046 |
15 | Myokymia (HP:0002411) | 3.45633228 |
16 | Gastrointestinal infarctions (HP:0005244) | 3.36936289 |
17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.35338087 |
18 | Dialeptic seizures (HP:0011146) | 3.23012875 |
19 | Keratoconjunctivitis (HP:0001096) | 3.22614769 |
20 | Abnormal hair whorl (HP:0010721) | 3.22155875 |
21 | Gingivitis (HP:0000230) | 3.19493995 |
22 | Disinhibition (HP:0000734) | 3.19110181 |
23 | Systemic lupus erythematosus (HP:0002725) | 3.15257213 |
24 | Absence seizures (HP:0002121) | 3.12387749 |
25 | Orchitis (HP:0100796) | 3.10236034 |
26 | Myositis (HP:0100614) | 3.07803891 |
27 | Generalized tonic-clonic seizures (HP:0002069) | 3.06873906 |
28 | Loss of speech (HP:0002371) | 3.04862661 |
29 | Visual hallucinations (HP:0002367) | 2.97350018 |
30 | Abnormality of macrophages (HP:0004311) | 2.93893449 |
31 | Progressive cerebellar ataxia (HP:0002073) | 2.91386794 |
32 | Hemoptysis (HP:0002105) | 2.90154985 |
33 | Prostate neoplasm (HP:0100787) | 2.89110064 |
34 | Optic neuritis (HP:0100653) | 2.86400669 |
35 | Retrobulbar optic neuritis (HP:0100654) | 2.86400669 |
36 | T lymphocytopenia (HP:0005403) | 2.85822807 |
37 | Encephalitis (HP:0002383) | 2.80190910 |
38 | Amyloidosis (HP:0011034) | 2.80115444 |
39 | Dysostosis multiplex (HP:0000943) | 2.79476088 |
40 | Stomatitis (HP:0010280) | 2.77431303 |
41 | Abnormality of T cell number (HP:0011839) | 2.72545454 |
42 | Gangrene (HP:0100758) | 2.64145211 |
43 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.62831318 |
44 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.62831318 |
45 | Abnormality of glycolipid metabolism (HP:0010969) | 2.62831318 |
46 | Inability to walk (HP:0002540) | 2.61394949 |
47 | Protruding tongue (HP:0010808) | 2.61214426 |
48 | Recurrent skin infections (HP:0001581) | 2.59591622 |
49 | Neurofibrillary tangles (HP:0002185) | 2.52021496 |
50 | Arterial thrombosis (HP:0004420) | 2.49300677 |
51 | Neuronal loss in central nervous system (HP:0002529) | 2.47410067 |
52 | Progressive neurologic deterioration (HP:0002344) | 2.42524529 |
53 | Inappropriate behavior (HP:0000719) | 2.42494922 |
54 | Vasculitis (HP:0002633) | 2.41774527 |
55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.41366616 |
56 | Obstructive lung disease (HP:0006536) | 2.41366616 |
57 | Episodic fever (HP:0001954) | 2.40486687 |
58 | Pulmonary embolism (HP:0002204) | 2.39442265 |
59 | Recurrent fungal infections (HP:0002841) | 2.38397001 |
60 | Amblyopia (HP:0000646) | 2.37944835 |
61 | Progressive inability to walk (HP:0002505) | 2.35561705 |
62 | Reduced antithrombin III activity (HP:0001976) | 2.35300247 |
63 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.34692447 |
64 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.34692447 |
65 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.34692447 |
66 | Diminished motivation (HP:0000745) | 2.33979658 |
67 | Memory impairment (HP:0002354) | 2.32611078 |
68 | Apathy (HP:0000741) | 2.30901063 |
69 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.30341029 |
70 | Anorexia (HP:0002039) | 2.27726877 |
71 | Autoimmune thrombocytopenia (HP:0001973) | 2.27615482 |
72 | Hypochromic microcytic anemia (HP:0004840) | 2.26337057 |
73 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.25857577 |
74 | Mucopolysacchariduria (HP:0008155) | 2.25857577 |
75 | Gingival bleeding (HP:0000225) | 2.25670255 |
76 | Failure to thrive in infancy (HP:0001531) | 2.24746818 |
77 | Increased cerebral lipofuscin (HP:0011813) | 2.22886210 |
78 | Leukocytosis (HP:0001974) | 2.22173032 |
79 | Absent speech (HP:0001344) | 2.21192062 |
80 | Chest pain (HP:0100749) | 2.20187509 |
81 | Horizontal nystagmus (HP:0000666) | 2.18950023 |
82 | Absent frontal sinuses (HP:0002688) | 2.18903599 |
83 | Pulmonary infiltrates (HP:0002113) | 2.16285807 |
84 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.15719817 |
85 | Hypoplasia of the fovea (HP:0007750) | 2.15540559 |
86 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.15540559 |
87 | Vertigo (HP:0002321) | 2.13808717 |
88 | Myocardial infarction (HP:0001658) | 2.12430329 |
89 | Tetraparesis (HP:0002273) | 2.12132784 |
90 | Abnormality of the pleura (HP:0002103) | 2.11706419 |
91 | Purpura (HP:0000979) | 2.11050982 |
92 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.08440346 |
93 | Supranuclear gaze palsy (HP:0000605) | 2.07022302 |
94 | Generalized hypopigmentation (HP:0007513) | 2.06420808 |
95 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.06049503 |
96 | Recurrent cutaneous fungal infections (HP:0011370) | 2.05932136 |
97 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.05932136 |
98 | Joint swelling (HP:0001386) | 2.05164628 |
99 | Autoimmune hemolytic anemia (HP:0001890) | 2.04686706 |
100 | Polyphagia (HP:0002591) | 2.04624193 |
101 | Hypokinesia (HP:0002375) | 2.03828170 |
102 | Increased serum ferritin (HP:0003281) | 2.03511356 |
103 | Upper motor neuron abnormality (HP:0002127) | 2.02874307 |
104 | Gait imbalance (HP:0002141) | 2.02119294 |
105 | Hepatosplenomegaly (HP:0001433) | 2.02000533 |
106 | Bilateral microphthalmos (HP:0007633) | 2.01530225 |
107 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.01398112 |
108 | Excessive salivation (HP:0003781) | 2.00059688 |
109 | Drooling (HP:0002307) | 2.00059688 |
110 | Cellulitis (HP:0100658) | 1.99537284 |
111 | Polyneuropathy (HP:0001271) | 1.99110550 |
112 | Gaze-evoked nystagmus (HP:0000640) | 1.96383340 |
113 | Increased IgE level (HP:0003212) | 1.96156809 |
114 | Interstitial pulmonary disease (HP:0006530) | 1.94018863 |
115 | Amaurosis fugax (HP:0100576) | 1.93328824 |
116 | Hematochezia (HP:0002573) | 1.93117815 |
117 | Osteomyelitis (HP:0002754) | 1.91569612 |
118 | Slow saccadic eye movements (HP:0000514) | 1.91015046 |
119 | Generalized hypopigmentation of hair (HP:0011358) | 1.90180772 |
120 | Chronic otitis media (HP:0000389) | 1.89326882 |
121 | Glomerulonephritis (HP:0000099) | 1.88722445 |
122 | Cerebral inclusion bodies (HP:0100314) | 1.87905655 |
123 | Hypergammaglobulinemia (HP:0010702) | 1.87831794 |
124 | Abnormality of the endocardium (HP:0004306) | 1.87272478 |
125 | Glomerulopathy (HP:0100820) | 1.85730680 |
126 | Abnormality of the prostate (HP:0008775) | 1.85126196 |
127 | Spontaneous hematomas (HP:0007420) | 1.83843166 |
128 | Limb dystonia (HP:0002451) | 1.83675582 |
129 | Congenital primary aphakia (HP:0007707) | 1.83093879 |
130 | Abnormality of the periventricular white matter (HP:0002518) | 1.80842980 |
131 | Abnormality of T cells (HP:0002843) | 1.79590495 |
132 | Recurrent viral infections (HP:0004429) | 1.78805889 |
133 | Periodontitis (HP:0000704) | 1.78233781 |
134 | Abnormality of the fovea (HP:0000493) | 1.77934819 |
135 | Agnosia (HP:0010524) | 1.77868591 |
136 | Dyschromatopsia (HP:0007641) | 1.76992754 |
137 | Medial flaring of the eyebrow (HP:0010747) | 1.76093592 |
138 | Nephrogenic diabetes insipidus (HP:0009806) | 1.76024417 |
139 | Iris hypopigmentation (HP:0007730) | 1.75949065 |
140 | Hemiparesis (HP:0001269) | 1.75771368 |
141 | Vacuolated lymphocytes (HP:0001922) | 1.75322660 |
142 | Basal ganglia calcification (HP:0002135) | 1.74689390 |
143 | Urticaria (HP:0001025) | 1.74624133 |
144 | Diplopia (HP:0000651) | 1.74020376 |
145 | Abnormality of binocular vision (HP:0011514) | 1.74020376 |
146 | Broad-based gait (HP:0002136) | 1.73800831 |
147 | Bradykinesia (HP:0002067) | 1.73154122 |
148 | Fair hair (HP:0002286) | 1.72431889 |
149 | Oligomenorrhea (HP:0000876) | 1.72289023 |
150 | Type I transferrin isoform profile (HP:0003642) | 1.72027971 |
151 | Exotropia (HP:0000577) | 1.71482457 |
152 | Mutism (HP:0002300) | 1.70729208 |
153 | Meningitis (HP:0001287) | 1.70656317 |
154 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.70374791 |
155 | Status epilepticus (HP:0002133) | 1.69996363 |
156 | Spastic tetraparesis (HP:0001285) | 1.68858577 |
157 | Abnormal eating behavior (HP:0100738) | 1.67822845 |
158 | Papilledema (HP:0001085) | 1.67072860 |
159 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.66051112 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 5.33930354 |
2 | MAP3K12 | 3.99124553 |
3 | GRK5 | 3.40183666 |
4 | NTRK3 | 3.04428308 |
5 | CASK | 2.65376151 |
6 | MAP2K7 | 2.47854008 |
7 | MAP3K14 | 2.47470935 |
8 | MAP4K1 | 2.23547557 |
9 | ADRBK2 | 2.22477071 |
10 | SIK3 | 2.10002644 |
11 | MAP2K4 | 2.04174344 |
12 | GRK7 | 2.02607926 |
13 | MAP3K9 | 2.02052752 |
14 | EPHA4 | 1.94449954 |
15 | MAP3K13 | 1.93657775 |
16 | PLK2 | 1.93479871 |
17 | DAPK2 | 1.92683103 |
18 | MATK | 1.89190739 |
19 | BMPR2 | 1.87019585 |
20 | MAP3K4 | 1.82490563 |
21 | DAPK1 | 1.79419145 |
22 | CAMKK2 | 1.63368473 |
23 | TAOK3 | 1.62124170 |
24 | KIT | 1.59314291 |
25 | MINK1 | 1.57879403 |
26 | MAP3K11 | 1.57568224 |
27 | PRPF4B | 1.50174116 |
28 | IRAK4 | 1.48561181 |
29 | TNIK | 1.46005344 |
30 | BLK | 1.43765818 |
31 | MAP2K3 | 1.43286051 |
32 | TBK1 | 1.42484286 |
33 | CDK12 | 1.34690074 |
34 | TAOK1 | 1.34061587 |
35 | ARAF | 1.27152469 |
36 | NTRK1 | 1.25036714 |
37 | IRAK2 | 1.24368433 |
38 | TXK | 1.21282084 |
39 | AKT3 | 1.18049299 |
40 | GRK6 | 1.16775033 |
41 | MAP3K2 | 1.16223367 |
42 | CSF1R | 1.14860670 |
43 | IRAK1 | 1.13611982 |
44 | SYK | 1.13359907 |
45 | IKBKE | 1.11492326 |
46 | FES | 1.09528551 |
47 | MAP3K6 | 1.06524416 |
48 | YES1 | 1.06265142 |
49 | MARK1 | 1.05391043 |
50 | BTK | 1.03195424 |
51 | IKBKB | 1.02426415 |
52 | GRK1 | 1.02376946 |
53 | MAP3K3 | 0.95552333 |
54 | CAMKK1 | 0.93197090 |
55 | SIK2 | 0.91519991 |
56 | PBK | 0.91239509 |
57 | ADRBK1 | 0.89255214 |
58 | JAK3 | 0.88695495 |
59 | KSR2 | 0.86455340 |
60 | BMPR1B | 0.85971057 |
61 | FGR | 0.83144757 |
62 | EIF2AK2 | 0.79164686 |
63 | ITK | 0.78876380 |
64 | IRAK3 | 0.77354472 |
65 | TYK2 | 0.77124337 |
66 | JAK1 | 0.76775075 |
67 | TNK2 | 0.74978875 |
68 | KSR1 | 0.73197649 |
69 | PRKCG | 0.71857036 |
70 | SGK2 | 0.71412072 |
71 | ERN1 | 0.71385842 |
72 | MAPK13 | 0.68564787 |
73 | MAP3K5 | 0.68265486 |
74 | CAMK4 | 0.67964591 |
75 | DDR2 | 0.65873360 |
76 | FYN | 0.65575650 |
77 | MOS | 0.65503158 |
78 | CDK19 | 0.65458666 |
79 | PDPK1 | 0.63642003 |
80 | ACVR1B | 0.63299986 |
81 | LYN | 0.61314993 |
82 | FGFR3 | 0.60453063 |
83 | CDK5 | 0.58550421 |
84 | EPHB1 | 0.58029098 |
85 | MARK3 | 0.56792630 |
86 | MAPK7 | 0.56738679 |
87 | PRKCD | 0.56705091 |
88 | PRKCE | 0.54478312 |
89 | FGFR4 | 0.52911575 |
90 | HCK | 0.51284930 |
91 | PRKCQ | 0.51207723 |
92 | ALK | 0.50790763 |
93 | ABL2 | 0.48972577 |
94 | CCNB1 | 0.48471013 |
95 | MAPK12 | 0.47819837 |
96 | RIPK1 | 0.47432612 |
97 | PDK1 | 0.46756248 |
98 | ERBB3 | 0.46670838 |
99 | MAP3K1 | 0.46508434 |
100 | MAP2K6 | 0.46319476 |
101 | CAMK2A | 0.45898068 |
102 | NTRK2 | 0.44855032 |
103 | LCK | 0.44787374 |
104 | CDC42BPA | 0.41263236 |
105 | ABL1 | 0.41187041 |
106 | NME2 | 0.40282488 |
107 | CHUK | 0.38716511 |
108 | EPHA3 | 0.38226031 |
109 | PRKG2 | 0.38151853 |
110 | RAF1 | 0.37739569 |
111 | SGK1 | 0.36656271 |
112 | PIM2 | 0.35738529 |
113 | MARK2 | 0.34750255 |
114 | SGK3 | 0.34141758 |
115 | TEC | 0.32175978 |
116 | CAMK1 | 0.31975576 |
117 | ZAP70 | 0.31873291 |
118 | BRD4 | 0.30562028 |
119 | OXSR1 | 0.30064484 |
120 | JAK2 | 0.29122251 |
121 | RPS6KA2 | 0.28553749 |
122 | CSK | 0.27878255 |
123 | TAOK2 | 0.26245276 |
124 | STK11 | 0.25758832 |
125 | TRIM28 | 0.25660283 |
126 | PAK6 | 0.25185033 |
127 | MAPK4 | 0.24526908 |
128 | PINK1 | 0.24308284 |
129 | TGFBR2 | 0.24218799 |
130 | EGFR | 0.24195017 |
131 | CDK14 | 0.23685178 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.11333652 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.93289137 |
3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.80857774 |
4 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.25859590 |
5 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.24419120 |
6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.09844688 |
7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.06077662 |
8 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.98848090 |
9 | Leishmaniasis_Homo sapiens_hsa05140 | 1.95815300 |
10 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.90687356 |
11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.90542423 |
12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.88949489 |
13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.88625151 |
14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.85805577 |
15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.82829486 |
16 | Morphine addiction_Homo sapiens_hsa05032 | 1.77476457 |
17 | GABAergic synapse_Homo sapiens_hsa04727 | 1.76906965 |
18 | Long-term potentiation_Homo sapiens_hsa04720 | 1.67195359 |
19 | Tuberculosis_Homo sapiens_hsa05152 | 1.66921889 |
20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.65310429 |
21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.64579325 |
22 | Allograft rejection_Homo sapiens_hsa05330 | 1.62366711 |
23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.59579053 |
24 | Phagosome_Homo sapiens_hsa04145 | 1.57861743 |
25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.57371608 |
26 | Taste transduction_Homo sapiens_hsa04742 | 1.53775926 |
27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.52688556 |
28 | Circadian entrainment_Homo sapiens_hsa04713 | 1.49059395 |
29 | Legionellosis_Homo sapiens_hsa05134 | 1.48378226 |
30 | Pertussis_Homo sapiens_hsa05133 | 1.46599555 |
31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.42498538 |
32 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.35882251 |
33 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.35485063 |
34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.32125285 |
35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.31106298 |
36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.30272114 |
37 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.29837559 |
38 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.29075318 |
39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.23639175 |
40 | Influenza A_Homo sapiens_hsa05164 | 1.22533621 |
41 | Salivary secretion_Homo sapiens_hsa04970 | 1.21867381 |
42 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.19293206 |
43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17942767 |
44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.16821516 |
45 | Salmonella infection_Homo sapiens_hsa05132 | 1.15885051 |
46 | Asthma_Homo sapiens_hsa05310 | 1.15857870 |
47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15193209 |
48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15157798 |
49 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14754852 |
50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.14184760 |
51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.13942312 |
52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.13737386 |
53 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.12750239 |
54 | Phototransduction_Homo sapiens_hsa04744 | 1.10841516 |
55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09340906 |
56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.08264294 |
57 | Renin secretion_Homo sapiens_hsa04924 | 1.08241830 |
58 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.03461322 |
59 | Long-term depression_Homo sapiens_hsa04730 | 1.03127598 |
60 | Measles_Homo sapiens_hsa05162 | 1.00910610 |
61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.99310344 |
62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93153893 |
63 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.85518935 |
64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.84332008 |
65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84299254 |
66 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.82190423 |
67 | Insulin secretion_Homo sapiens_hsa04911 | 0.79517174 |
68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.79302228 |
69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78904874 |
70 | Malaria_Homo sapiens_hsa05144 | 0.78691781 |
71 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.78554143 |
72 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.78146815 |
73 | Lysosome_Homo sapiens_hsa04142 | 0.76792050 |
74 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75627164 |
75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72921282 |
76 | Cocaine addiction_Homo sapiens_hsa05030 | 0.65739991 |
77 | Shigellosis_Homo sapiens_hsa05131 | 0.63893720 |
78 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.63177204 |
79 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.62064016 |
80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.60396010 |
81 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.60265520 |
82 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.60211760 |
83 | Hepatitis C_Homo sapiens_hsa05160 | 0.59897828 |
84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59141023 |
85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.58939980 |
86 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.58576119 |
87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57337508 |
88 | Platelet activation_Homo sapiens_hsa04611 | 0.57095573 |
89 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.57079715 |
90 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.53965468 |
91 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.53024670 |
92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52846098 |
93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52502137 |
94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51831470 |
95 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51009076 |
96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48535723 |
97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48085198 |
98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47972409 |
99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47793669 |
100 | Glioma_Homo sapiens_hsa05214 | 0.47321954 |
101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47110250 |
102 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.47053687 |
103 | Hepatitis B_Homo sapiens_hsa05161 | 0.46319604 |
104 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45834060 |
105 | Prion diseases_Homo sapiens_hsa05020 | 0.45661098 |
106 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.44821300 |
107 | Alzheimers disease_Homo sapiens_hsa05010 | 0.43129532 |
108 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.41237988 |
109 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40735749 |
110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40607609 |
111 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.40375023 |
112 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39035125 |
113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38962173 |
114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37767827 |
115 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.37713172 |
116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37706307 |
117 | Amoebiasis_Homo sapiens_hsa05146 | 0.37613275 |
118 | Apoptosis_Homo sapiens_hsa04210 | 0.37538821 |
119 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.35245813 |
120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.35111142 |
121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35032517 |
122 | Endocytosis_Homo sapiens_hsa04144 | 0.33113709 |
123 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.32147472 |
124 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29614287 |
125 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.25934608 |
126 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.25114588 |
127 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.23985230 |
128 | Mineral absorption_Homo sapiens_hsa04978 | 0.22640589 |
129 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.21945834 |
130 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.20540142 |